Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo.

Shen, Chen-Tian

Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo. [electronic resource] - Journal of molecular endocrinology 01 2017 - 15-23 p. digital

Publication Type: Journal Article

1479-6813

10.1530/JME-16-0134 doi


AMP-Activated Protein Kinases--metabolism
Animals
Carcinoma, Papillary--diagnostic imaging
Cell Line, Tumor
Cell Survival
Disease Models, Animal
Female
Fluorodeoxyglucose F18
Gene Expression
Glucose--metabolism
Glucose Transporter Type 1--genetics
Heterografts
Hexokinase--genetics
Humans
Immunohistochemistry
Metabolic Networks and Pathways--drug effects
Metformin--pharmacology
Positron Emission Tomography Computed Tomography--methods
Proto-Oncogene Proteins c-akt--metabolism
Signal Transduction
TOR Serine-Threonine Kinases--metabolism
Thyroid Cancer, Papillary
Thyroid Neoplasms--diagnostic imaging